34. Hanamoto S, Nakada N, Yamashita N, Tanaka H (2018) Source estimation of pharmaceuticals
based on catchment population and in-stream attenuation in Yodo River watershed, Japan. Sci
Total Environ 615:964–971
35. Čelić M, Gros M, Farré M, Barceló D, Petrović M (2019) Pharmaceuticals as chemical markers
of wastewater contamination in the vulnerable area of the Ebro Delta (Spain). Sci Total Environ
652:952–963
36. Kostich MS, Batt AL, Lazorchak JM (2014) Concentrations of prioritized pharmaceuticals in
effluents from 50 large wastewater treatment plants in the US and implications for risk
estimation. Environ Pollut 184:354–359
37. Liu JL, Wong MH (2013) Pharmaceuticals and personal care products (PPCPs): a review on
environmental contamination in China. Environ Int 59:208–224
38. Munro K, Martins CP, Loewenthal M, Comber S, Cowan DA, Pereira L, Barron LP (2019)
Evaluation of combined sewer overflow impacts on short-term pharmaceutical and illicit drug
occurrence in a heavily urbanised tidal river catchment (London, UK). Sci Total Environ
657:1099–1111
39. Spataro F, Ademollo N, Pescatore T, Rauseo J, Patrolecco L (2019) Antibiotic residues and
endocrine disrupting compounds in municipal wastewater treatment plants in Rome, Italy.
Microchem J 148:634–642
40. Thalla AK, Vannarath AS (2020) Occurrence and environmental risks of non-steroidal antiinflammatory drugs in urban wastewater in the southwest monsoon region of India. Environ
Monit Assess 192(3):1–13
41. Felis E, Kalka J, Sochacki A, Kowalska K, Bajkacz S, Harnisz M, Korzeniewska E (2020)
Antimicrobial pharmaceuticals in the aquatic environment-occurrence and environmental implications. Eur J Pharmacol 866:172813
42. Nantaba F, Wasswa J, Kylin H, Palm WU, Bouwman H, Kümmerer K (2020) Occurrence,
distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in
water from Lake Victoria, Uganda. Chemosphere 239:124642
43. Su D, Ben W, Strobel BW, Qiang Z (2020) Occurrence, source estimation and risk assessment
of pharmaceuticals in the Chaobai River characterized by adjacent land use. Sci Total Environ
712:134525
44. Reis EO, Foureaux AFS, Rodrigues JS, Moreira VR, Lebron YA, Santos LV et al (2019)
Occurrence, removal and seasonal variation of pharmaceuticals in Brasilian drinking water
treatment plants. Environ Pollut 250:773–781
45. Greenham RT, Miller KY, Tong A (2019) Removal efficiencies of top-used pharmaceuticals at
sewage treatment plants with various technologies. J Environ Chem Eng 7(5):103294
46. Kleywegt S, Payne M, Ng F, Fletcher T (2019) Environmental loadings of active pharmaceutical ingredients from manufacturing facilities in Canada. Sci Total Environ 646:257–264
47. Kołecka K, Gajewska M, Stepnowski P, Caban M (2019) Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with sludge treatment reed beds technology. Sci
Total Environ 647:149–157
48. Afonso-Olivares C, Sosa-Ferrera Z, Santana-Rodríguez JJ (2017) Occurrence and environmental impact of pharmaceutical residues from conventional and natural wastewater treatment
plants in Gran Canaria (Spain). Sci Total Environ 599:934–943
49. Liu HQ, Lam JC, Li WW, Yu HQ, Lam PK (2017) Spatial distribution and removal performance of pharmaceuticals in municipal wastewater treatment plants in China. Sci Total Environ
586:1162–1169
50. Harrison EZ, Oakes SR, Hysell M, Hay A (2006) Organic chemicals in sewage sludges. Sci
Total Environ 367(2–3):481–497
51. Gunningham N, Sinclair D (2005) Policy instrument choice and diffuse source pollution. J
Environ Law 17(1):51–81
52. Ribaudo M, Horan RD, Smith ME (1999) Economics of water quality protection from
non-point sources; theory and practice. In: Ribaudo MO, Horan RD, Smith ME (eds) Agricultural economic report; no. 782 an economic research service report
46
R. Parra-Saldivar et al.
based on catchment population and in-stream attenuation in Yodo River watershed, Japan. Sci
Total Environ 615:964–971
35. Čelić M, Gros M, Farré M, Barceló D, Petrović M (2019) Pharmaceuticals as chemical markers
of wastewater contamination in the vulnerable area of the Ebro Delta (Spain). Sci Total Environ
652:952–963
36. Kostich MS, Batt AL, Lazorchak JM (2014) Concentrations of prioritized pharmaceuticals in
effluents from 50 large wastewater treatment plants in the US and implications for risk
estimation. Environ Pollut 184:354–359
37. Liu JL, Wong MH (2013) Pharmaceuticals and personal care products (PPCPs): a review on
environmental contamination in China. Environ Int 59:208–224
38. Munro K, Martins CP, Loewenthal M, Comber S, Cowan DA, Pereira L, Barron LP (2019)
Evaluation of combined sewer overflow impacts on short-term pharmaceutical and illicit drug
occurrence in a heavily urbanised tidal river catchment (London, UK). Sci Total Environ
657:1099–1111
39. Spataro F, Ademollo N, Pescatore T, Rauseo J, Patrolecco L (2019) Antibiotic residues and
endocrine disrupting compounds in municipal wastewater treatment plants in Rome, Italy.
Microchem J 148:634–642
40. Thalla AK, Vannarath AS (2020) Occurrence and environmental risks of non-steroidal antiinflammatory drugs in urban wastewater in the southwest monsoon region of India. Environ
Monit Assess 192(3):1–13
41. Felis E, Kalka J, Sochacki A, Kowalska K, Bajkacz S, Harnisz M, Korzeniewska E (2020)
Antimicrobial pharmaceuticals in the aquatic environment-occurrence and environmental implications. Eur J Pharmacol 866:172813
42. Nantaba F, Wasswa J, Kylin H, Palm WU, Bouwman H, Kümmerer K (2020) Occurrence,
distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in
water from Lake Victoria, Uganda. Chemosphere 239:124642
43. Su D, Ben W, Strobel BW, Qiang Z (2020) Occurrence, source estimation and risk assessment
of pharmaceuticals in the Chaobai River characterized by adjacent land use. Sci Total Environ
712:134525
44. Reis EO, Foureaux AFS, Rodrigues JS, Moreira VR, Lebron YA, Santos LV et al (2019)
Occurrence, removal and seasonal variation of pharmaceuticals in Brasilian drinking water
treatment plants. Environ Pollut 250:773–781
45. Greenham RT, Miller KY, Tong A (2019) Removal efficiencies of top-used pharmaceuticals at
sewage treatment plants with various technologies. J Environ Chem Eng 7(5):103294
46. Kleywegt S, Payne M, Ng F, Fletcher T (2019) Environmental loadings of active pharmaceutical ingredients from manufacturing facilities in Canada. Sci Total Environ 646:257–264
47. Kołecka K, Gajewska M, Stepnowski P, Caban M (2019) Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with sludge treatment reed beds technology. Sci
Total Environ 647:149–157
48. Afonso-Olivares C, Sosa-Ferrera Z, Santana-Rodríguez JJ (2017) Occurrence and environmental impact of pharmaceutical residues from conventional and natural wastewater treatment
plants in Gran Canaria (Spain). Sci Total Environ 599:934–943
49. Liu HQ, Lam JC, Li WW, Yu HQ, Lam PK (2017) Spatial distribution and removal performance of pharmaceuticals in municipal wastewater treatment plants in China. Sci Total Environ
586:1162–1169
50. Harrison EZ, Oakes SR, Hysell M, Hay A (2006) Organic chemicals in sewage sludges. Sci
Total Environ 367(2–3):481–497
51. Gunningham N, Sinclair D (2005) Policy instrument choice and diffuse source pollution. J
Environ Law 17(1):51–81
52. Ribaudo M, Horan RD, Smith ME (1999) Economics of water quality protection from
non-point sources; theory and practice. In: Ribaudo MO, Horan RD, Smith ME (eds) Agricultural economic report; no. 782 an economic research service report
46
R. Parra-Saldivar et al.